Skip to main content
Top
Published in: Annals of Hematology 12/2019

01-12-2019 | Lymphoma | Letter to the Editor

Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma

Authors: Carlos Bravo-Perez, Inmaculada Pajares, Begoña Muiña, Hugo Escobar, Ma Luz Amigo, Ma Dolores Garcia-Malo, Jonathan Garcia, Socorro María Rodriguez-Pinilla, Miguel Angel Piris, Francisco Jose Ortuño

Published in: Annals of Hematology | Issue 12/2019

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
go back to reference Geyer JT, Subramaniyam S, Jiang Y, Elemento O, Ferry JA, de Leval L, Nakashima MO, Liu YC, Martin P, Mathew S, Orazi A, Tam W (2015) Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients. Hum Pathol 46:260–271CrossRef Geyer JT, Subramaniyam S, Jiang Y, Elemento O, Ferry JA, de Leval L, Nakashima MO, Liu YC, Martin P, Mathew S, Orazi A, Tam W (2015) Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients. Hum Pathol 46:260–271CrossRef
2.
go back to reference Kluin P, Harris NL, Stein H, Leoncini L, Campo E, Jaffe ES, Gascoyne RD, Swerdlow SH (2017) High grade B-cell lymphoma. In: WHO classification of tumours of hematopoietic and lymphoid tissue. WHO IARC Press, pp 335–341 Kluin P, Harris NL, Stein H, Leoncini L, Campo E, Jaffe ES, Gascoyne RD, Swerdlow SH (2017) High grade B-cell lymphoma. In: WHO classification of tumours of hematopoietic and lymphoid tissue. WHO IARC Press, pp 335–341
3.
go back to reference Moench L, Sachs Z, Aasen G, Dolan M, Dayton V, Courville EL (2016) Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges. Leuk Lymphoma 57:2626–2635CrossRef Moench L, Sachs Z, Aasen G, Dolan M, Dayton V, Courville EL (2016) Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges. Leuk Lymphoma 57:2626–2635CrossRef
4.
go back to reference Slot LM, Hoogeboom R, Smit LA, Wormhoudt TA, Biemond BJ, Oud ME, Schilder-Tol EJ, Mulder AB, Jongejan A, van Kampen AH, Kluin PM, Guikema JE, Bende RJ, van Noesel CJ (2016) B-Lymphoblastic lymphomas evolving from follicular lymphomas co-express surrogate light chains and mutated gamma heavy chains. Am J Pathol 186:3273–3284CrossRef Slot LM, Hoogeboom R, Smit LA, Wormhoudt TA, Biemond BJ, Oud ME, Schilder-Tol EJ, Mulder AB, Jongejan A, van Kampen AH, Kluin PM, Guikema JE, Bende RJ, van Noesel CJ (2016) B-Lymphoblastic lymphomas evolving from follicular lymphomas co-express surrogate light chains and mutated gamma heavy chains. Am J Pathol 186:3273–3284CrossRef
5.
go back to reference Ok CY, Medeiros LJ, Thakral B, Tang G, Jain N, Jabbour E, Pierce SA, Konoplev S (2019) High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma. Mod Pathol 32(1):48–58CrossRef Ok CY, Medeiros LJ, Thakral B, Tang G, Jain N, Jabbour E, Pierce SA, Konoplev S (2019) High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma. Mod Pathol 32(1):48–58CrossRef
6.
go back to reference Mamessier E, Broussais-Guillaumot F, Chetaille B, Bouabdallah R, Xerri L, Jaffe ES, Nadel B (2014) Nature and importance of follicular lymphoma precursors. Haematologica 99:802–810CrossRef Mamessier E, Broussais-Guillaumot F, Chetaille B, Bouabdallah R, Xerri L, Jaffe ES, Nadel B (2014) Nature and importance of follicular lymphoma precursors. Haematologica 99:802–810CrossRef
7.
go back to reference Merron B, Davies A (2018) Double hit lymphoma: how do we define it and how do we treat it? Best Pract Res Clin Haematol 31:233–240CrossRef Merron B, Davies A (2018) Double hit lymphoma: how do we define it and how do we treat it? Best Pract Res Clin Haematol 31:233–240CrossRef
8.
go back to reference Cohen JB (2018) Novel therapies for relapsed/refractory aggressive lymphomas. Hematol Am Soc Hematol Educ Program 30(1):75–82CrossRef Cohen JB (2018) Novel therapies for relapsed/refractory aggressive lymphomas. Hematol Am Soc Hematol Educ Program 30(1):75–82CrossRef
9.
go back to reference Sha C, Barrans S, Cucco F, Bentley MA, Care MA, Cummin T, Kennedy H, Thompson JS, Uddin R, Worrillow L, Chalkley R, van Hoppe M, Ahmed S, Maishman T, Caddy J, Schuh A, Mamot C, Burton C, Tooze R, Davies A, Du MQ, Johnson PWM, Westhead DR (2018) Molecular high-grade B-cell lymphoma: defining a poor-risk group that requires different approaches to therapy. J Clin Oncol 37:1–11 Sha C, Barrans S, Cucco F, Bentley MA, Care MA, Cummin T, Kennedy H, Thompson JS, Uddin R, Worrillow L, Chalkley R, van Hoppe M, Ahmed S, Maishman T, Caddy J, Schuh A, Mamot C, Burton C, Tooze R, Davies A, Du MQ, Johnson PWM, Westhead DR (2018) Molecular high-grade B-cell lymphoma: defining a poor-risk group that requires different approaches to therapy. J Clin Oncol 37:1–11
Metadata
Title
Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma
Authors
Carlos Bravo-Perez
Inmaculada Pajares
Begoña Muiña
Hugo Escobar
Ma Luz Amigo
Ma Dolores Garcia-Malo
Jonathan Garcia
Socorro María Rodriguez-Pinilla
Miguel Angel Piris
Francisco Jose Ortuño
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 12/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-019-03829-1

Other articles of this Issue 12/2019

Annals of Hematology 12/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.